Drugmakers Court Small Firms in Push to Fill Thinning Pipelines

March 30, 2005

In an environment where big drug companies are furiously courting biotechnology companies for licensing deals, Ron Cohen is a hot date. The chief executive of Acorda Therapeutics Inc. in Hawthorne, N.Y., is seeking deep-pocket partners to help him develop new treatments for multiple sclerosis and spinal cord injuries. That makes him potentially attractive to a pharmaceutical industry that doesn't have many new drugs of its own to work on.

The Boston Globe (http://www.boston.com/business/globe/articles/2005/03/29/drug_makers_court_small_firms_in_push_to_fill_thinning_pipelines/)